tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:BCT Stock Latest News

BriaCell Unveils Promising Anti-Cancer Data for Bria-OTS+ Platform
Company AnnouncementsBriaCell Unveils Promising Anti-Cancer Data for Bria-OTS+ Platform
7d ago
BCTX
BriaCell presents anti-cancer activity of Bria-OTS at SITC 2025
PremiumThe Fly
BriaCell presents anti-cancer activity of Bria-OTS at SITC 2025
7d ago
BCTX
BriaCell to Showcase Promising Cancer Immunotherapy Platform at SITC Meeting
PremiumCompany Announcements
BriaCell to Showcase Promising Cancer Immunotherapy Platform at SITC Meeting
10d ago
BCTX
BriaCell’s Innovative Approach in Breast Cancer Treatment: A Study Update
PremiumCompany Announcements
BriaCell’s Innovative Approach in Breast Cancer Treatment: A Study Update
17d ago
BCT
BriaCell’s Promising Breast Cancer Study: A Potential Game Changer?
PremiumCompany Announcements
BriaCell’s Promising Breast Cancer Study: A Potential Game Changer?
18d ago
BCT
BriaCell’s Phase 3 Study in Metastatic Breast Cancer Receives Positive DSMB Recommendation
PremiumCompany AnnouncementsBriaCell’s Phase 3 Study in Metastatic Breast Cancer Receives Positive DSMB Recommendation
23d ago
BCTX
BriaCell says DSMB recommends continuation of Phase 3 Bria-IMT study
Premium
The Fly
BriaCell says DSMB recommends continuation of Phase 3 Bria-IMT study
23d ago
BCTX
BriaCell Partners with MSK to Advance Cancer Immunotherapy
Premium
Company Announcements
BriaCell Partners with MSK to Advance Cancer Immunotherapy
24d ago
BCTX
BriaCell Expands Phase 3 Study in Metastatic Breast Cancer
PremiumCompany Announcements
BriaCell Expands Phase 3 Study in Metastatic Breast Cancer
24d ago
BCTX
BriaCell adds clinical sites in Phase 3 metastatic breast cancer study
PremiumThe Fly
BriaCell adds clinical sites in Phase 3 metastatic breast cancer study
24d ago
BCTX
BriaCell announces collaboration with MSK Accelerator Cohort program
PremiumThe Fly
BriaCell announces collaboration with MSK Accelerator Cohort program
24d ago
BCTX
BriaCell Reports Promising Phase 3 Data in Metastatic Breast Cancer Study
PremiumCompany Announcements
BriaCell Reports Promising Phase 3 Data in Metastatic Breast Cancer Study
25d ago
BCTX
BriaCell presents Phase 3 clinical biomarker data at ESMO 2025
PremiumThe FlyBriaCell presents Phase 3 clinical biomarker data at ESMO 2025
25d ago
BCTX
Promising Phase 3 Results for BriaCell’s Bria-IMT in Metastatic Breast Cancer
Premium
Ratings
Promising Phase 3 Results for BriaCell’s Bria-IMT in Metastatic Breast Cancer
1M ago
BCTX
BriaCell Reports Positive Phase 3 Biomarker Data for Metastatic Breast Cancer Treatment
Premium
Company Announcements
BriaCell Reports Positive Phase 3 Biomarker Data for Metastatic Breast Cancer Treatment
1M ago
BCTX
BriaCell to present clinical biomarker data of Phase 3 Bria-IMT study
PremiumThe Fly
BriaCell to present clinical biomarker data of Phase 3 Bria-IMT study
1M ago
BCTX
BriaCell to Present Innovative Cancer Vaccine Data at SITC 2025
PremiumCompany Announcements
BriaCell to Present Innovative Cancer Vaccine Data at SITC 2025
1M ago
BCTX
BriaCell Therapeutics: Strategic Advancements and Financial Strength Drive Buy Rating
PremiumRatings
BriaCell Therapeutics: Strategic Advancements and Financial Strength Drive Buy Rating
3M ago
BCTX
BriaCell’s Bria-OTS+ Platform Validated in Cancer Journal
PremiumCompany Announcements
BriaCell’s Bria-OTS+ Platform Validated in Cancer Journal
3M ago
BCTX
BriaCell’s Bria-OTS mechanism of action study published by JCI Insight
PremiumThe FlyBriaCell’s Bria-OTS mechanism of action study published by JCI Insight
3M ago
BCTX
BriaCell Secures $2 Million Grant for Prostate Cancer Immunotherapy
Premium
Company Announcements
BriaCell Secures $2 Million Grant for Prostate Cancer Immunotherapy
3M ago
BCTX
BriaCell awarded $2M NCI grant to advance Bria-POS+
Premium
The Fly
BriaCell awarded $2M NCI grant to advance Bria-POS+
3M ago
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >